pCMV5 HA-TBRII (delta Cyt) Citations (5)
Originally described in: Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis.Siegel PM, Shu W, Cardiff RD, Muller WJ, Massague J Proc Natl Acad Sci U S A. 2003 Jul 8. 100(14):8430-5. PubMed Journal
Articles Citing pCMV5 HA-TBRII (delta Cyt)
Articles |
---|
Divergent signaling pathways cooperatively regulate TGFbeta induction of cysteine-rich protein 2 in vascular smooth muscle cells. Wu ML, Chen CH, Lin YT, Jheng YJ, Ho YC, Yang LT, Chen L, Layne MD, Yet SF. Cell Commun Signal. 2014 Mar 28;12:22. doi: 10.1186/1478-811X-12-22. PubMed |
Altering the Proteoglycan State of Transforming Growth Factor beta Type III Receptor (TbetaRIII)/Betaglycan Modulates Canonical Wnt/beta-Catenin Signaling. Jenkins LM, Singh P, Varadaraj A, Lee NY, Shah S, Flores HV, O'Connell K, Mythreye K. J Biol Chem. 2016 Dec 2;291(49):25716-25728. doi: 10.1074/jbc.M116.748624. Epub 2016 Oct 26. PubMed |
Molecular definition of a metastatic lung cancer state reveals a targetable CD109-Janus kinase-Stat axis. Chuang CH, Greenside PG, Rogers ZN, Brady JJ, Yang D, Ma RK, Caswell DR, Chiou SH, Winters AF, Gruner BM, Ramaswami G, Spencley AL, Kopecky KE, Sayles LC, Sweet-Cordero EA, Li JB, Kundaje A, Winslow MM. Nat Med. 2017 Mar;23(3):291-300. doi: 10.1038/nm.4285. Epub 2017 Feb 13. PubMed |
TGF-beta triggers rapid fibrillogenesis via a novel TbetaRII-dependent fibronectin-trafficking mechanism. Varadaraj A, Jenkins LM, Singh P, Chanda A, Snider J, Lee NY, Amsalem-Zafran AR, Ehrlich M, Henis YI, Mythreye K. Mol Biol Cell. 2017 May 1;28(9):1195-1207. doi: 10.1091/mbc.E16-08-0601. Epub 2017 Mar 15. PubMed |
Simultaneous Inhibition of LSD1 and TGFbeta Enables Eradication of Poorly Immunogenic Tumors with Anti-PD-1 Treatment. Sheng W, Liu Y, Chakraborty D, Debo B, Shi Y. Cancer Discov. 2021 Aug;11(8):1970-1981. doi: 10.1158/2159-8290.CD-20-0017. Epub 2021 Mar 9. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.